By MELINDA J. OVERSTREET for Glasgow News 1 In September 2023, he had been fighting a cold for weeks and weeks. His immune ...

I share how traveling fueled my passion for life, how myeloma changed my journeys, and how new mobility options have opened ...

Multiple myeloma begins when abnormal cells multiply and grow uncontrollably in a person’s bone marrow, crowding out healthy ...

Celltrion USA today announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing PROLIA® ...

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events (MDEs) known as CRAB: C=Hypercalcemia R=Renal insufficiency A=Anemia B ...

Fresenius Kabi’s fifth and sixth biosimilars Conexxence (denosumab-bnht) and Bomyntra (denosumab-bnht) have launched in the ...

Fragile bone can sometimes fracture even from everyday activities, like lifting, sneezing, walking, or coughing. Fatigue and Weakness This is a common problem for people with multiple myeloma.

Multiple myeloma causes lytic or osteolytic lesions, which are areas of damage caused by cancerous plasma cells blocking normal bone growth. While painful, they can be managed. Multiple myeloma is ...

The first successful application of a similar procedure, ie, vertebroplasty was published in France by Deramond et al in 1987 in a patient who suffered a vertebral fracture from osteolysis caused ...

Like many closely-knit mothers and daughters, Noreen and Anne Hennessy love nothing more than hitting the shops together at ...

Fresenius announced that its operating company, Fresenius Kabi, has introduced two new biosimilars – Conexxence ...

EXCLUSIVE: A top doctor has shared five common symptoms which could be a sign that something is seriously wrong.